148 related articles for article (PubMed ID: 38284728)
1. Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta- Analysis and Systematic Review.
Hashemi Rafsanjani MR; Rahimi R; Heidari-Soureshjani S; Darvishi M; Adeli OA; Abbaszadeh S
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38284728
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.
Islam MM; Poly TN; Walther BA; Yang HC; Jack Li YC
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183029
[No Abstract] [Full Text] [Related]
4. The Association between Statins Intake and Risk of Post Stroke Pneumonia: A Systematic Review and Meta-Analysis.
Darvishi M; Amiri MM; Heidari-Soureshjani S; Sherwin CMT; Mardani-Nafchi H
Curr Rev Clin Exp Pharmacol; 2024; 19(3):285-293. PubMed ID: 37817662
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A
Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854
[TBL] [Abstract][Full Text] [Related]
6. Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review.
Khazaaleh S; Sarmini MT; Alomari M; Al Momani L; El Kurdi B; Asfari M; Almomani Z; Romero-Marrero C
Cureus; 2022 Jul; 14(7):e27032. PubMed ID: 35989795
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-analysis of the Relationship between Statin Intake and Esophageal Cancer.
Khaghani A; Kasiri K; Heidari-Soureshjani S; Sherwin CM; Mardani-Nafchi H
Anticancer Agents Med Chem; 2024 May; ():. PubMed ID: 38812422
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.
Wong YJ; Qiu TY; Ng GK; Zheng Q; Teo EK
J Clin Gastroenterol; 2021 Aug; 55(7):615-623. PubMed ID: 33606427
[TBL] [Abstract][Full Text] [Related]
9. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
10. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
Wang J; Li X
Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
[TBL] [Abstract][Full Text] [Related]
11. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
[TBL] [Abstract][Full Text] [Related]
12. The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis.
Pang Q; Jin H; Qu K; Man Z; Wang Y; Yang S; Zhou L; Liu H
Onco Targets Ther; 2017; 10():4645-4656. PubMed ID: 29033583
[TBL] [Abstract][Full Text] [Related]
13. Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Zhang J; Fu S; Liu D; Wang Y; Tan Y
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):353-358. PubMed ID: 36719824
[TBL] [Abstract][Full Text] [Related]
14. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
Li X; Liu L; Hu Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
[TBL] [Abstract][Full Text] [Related]
15. The association between folic acid supplementation and congenital heart defects: Systematic review and meta-analysis.
Wondemagegn AT; Afework M
SAGE Open Med; 2022; 10():20503121221081069. PubMed ID: 35284077
[TBL] [Abstract][Full Text] [Related]
16. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
[TBL] [Abstract][Full Text] [Related]
17. Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis.
Wang Z; Li S; Jia Y; Liu M; Yang K; Sui M; Liu D; Liang K
Front Oncol; 2022; 12():985281. PubMed ID: 36330502
[TBL] [Abstract][Full Text] [Related]
18. Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Xu H; Cao D; Zhou D; Zhao N; Tang X; Shelat VG; Samant H; Satapathy SK; Tustumi F; Aprile G; He A; Xu X; Ge W
BMC Cancer; 2023 Oct; 23(1):1006. PubMed ID: 37858207
[TBL] [Abstract][Full Text] [Related]
19. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
[TBL] [Abstract][Full Text] [Related]
20. Associations of statin use with the onset and progression of open-angle glaucoma: A systematic review and meta-analysis.
Yuan Y; Xiong R; Wu Y; Ha J; Wang W; Han X; He M
EClinicalMedicine; 2022 Apr; 46():101364. PubMed ID: 35399812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
